Business Intelligence Tool (BiT)


KMK’s BiT is a cloud-based sales reporting platform that delivers the right information at the right time, enabling you to make informed business decisions.

This comprehensive, end-to-end customized support platform provides all the data and reporting you need to build a productive, efficient and motivated sales force. With BiT, your reps and sales management can make better real-time decisions.

Related insights

Closing The Gap: 5 Key Drivers to Meet Unmet Medical Needs

KMK Consulting Inc. Earns Third Consecutive US Great Place to Work Certification™ in 2023!

KMK Solves the Puzzle of Product Commercialization with New Logo Launch

KMK 2023 Annual Award Ceremony

KMK Consulting Inc. Welcomes Paul Cariola as Lead Principal, Commercial Strategy

KMK Patient Journey Analysis Leads Global Pharma Brand To More Accurate Forecasting

The Patient Journey: Transforming Healthcare into Patientcare

Renee Daniels Named Global Head of Recruitment and HR at KMK Consulting Inc.

The Art of Leadership in the Emerging Biopharmaceutical Industry: Trends, Challenges, and Approaches

KMK Names Healthcare Veteran Stephen Deitch as Head of Global Market Access

The First Seven Miles – A Rare Disease Patient Journey

KMK Consulting Inc Appoints Chris Stevenson as Principal of Strategy in Europe

Sr. Associate, Advanced Analytics C00229

Associate, Data Analyst C00292

Consultant, Commercial Performance C00283

Senior Associate, Advanced Analytics C00300

Pharma 2023: Redefining the Roadmap Through a Commercial Lens

Data Analyst C00228

Drive Better Results: Using Technology in Your Product Commercialization Planning

Associate Consultant C00295

HEOR & RWE: The Path to Effective Drug Development

Forecasting in CAR T- Cell Therapy Assists in Setting Client Expectations for Patient Deliveries

Analytics Lead C00296

The Significance of Considering Psychological Aspects of Diabetes Patient Care

Uncovering an Accurate Target Call List for a Drug Treating Sickle Cell Disease  

Strategic Planning for Medical Affairs: Adding Value Efficiently

How We Promote Work-Life Flexibility

Associate Consultant, Data Science C00288

KMK Consulting Inc. Earns 2022 Great Place to Work-Certification in India! 

Latest Research Breakthroughs in Prostate Cancer Treatment 

Manager, Commercial Analytics C00104

KMK Names Shanique Turner as Director of Market Research

KMK Consulting Inc. Named 2022 Best Company for Women to Work

Now Is The Time To Use An Interactive Flow Diagram To Tell Patient Narratives

Supporting an Emerging Pharma Company’s Product Launch with an Integrated, End-to-End Data Management Platform 

Data Science & Stats Associate C00277

Big Data Analyst C00281

Developing an Incentive Compensation Plan To Better Attract, Motivate and Retain Sales Personnel Serving the Rare Disease Market 

Associate Consultant C00293

Associate Consultant, IT C00274

Associate C00275

Associate Consultant, Data Science C00272

Associate Consultant, Data Science C00271

Great Place to Work Certification

KMK Celebrates Being Certified as a “Great Place to Work” in USA & India

KMK Consulting Welcomes New Market Research Principal, Dan DeSantis

Ready, Set, Launch – Why Technology is Key to a Successful Product Launch

How To Avoid Costly Mistakes In Pre-launch?

Data Assessment In Action

Access Granted Webinar: Transforming the Customer Access Landscape

Consultant, Commercial Analytics C00101

Senior Associate, HEOR C00113

Manager, Commercial Analytics C00104

Lead Analyst C00106

Director, Commercial Analytics C00102

Data Scientist C00103

Commercial Analytics Consultant 258

Associate Data Analytics 589

Associate Director C00226

Analytics Manager C00105

KMK Consulting Inc. Donates to Underprivileged Children in India

The Invisible Customer: How Private Equity Owned Practices are Changing the Biopharma Industry

KMK Consulting Inc. Announces Dani Heywood as President

Vakhtang Agayan Named New CTO at KMK Consulting Inc.

The Art of Building a Flexible Sales Force During COVID-19

Localizing Your BioPharma Commercial Strategy

KMK Consulting, Inc. Launches On-Demand SME Network

KMK Donates to COVID Relief Effort in India


Making Remote Work in India with Pratik Panchal

KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™

Erenumab Study Demonstrates Significantly Reduced Acute Medication Usage and Health Care Utilization for Migraines

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Genentech, Pfizer and Merck Identified as the Top Three Companies Driving Therapeutic Innovation in Breast Cancer

How to become the Iron Man of Data Analytics?

Exploring the significance of Real World Evidence and Real World Data

HEOR Principal Huanxue Zhou’s Manuscript in BURNS Journal

HEOR Principal Huanxue Zhou’s Manuscript in International Journal of MS Care

Gritty and Fearless: How to succeed at KMK

East Meets West: The KMK Way

Learning the Ropes: An Intern’s Story at KMK

KMK Partners with Major Pharma Company in Recent RWE Study Analyzing Multiple Sclerosis Treatment Costs

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

High Cost of Medication Tops the List of Challenges for Gastroenterologists Treating IBS

What are the most important asthma products and what makes them superior?

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma

Real World Evidence to Support Payer Negotiation

Leverage Anonymized Patient-Level Data (APLD) to Identify Market Opportunities – KMK Consulting Inc

KMK Partners with Pharma Giant to Analyze Switching Costs of Biologic Treatments with Real World Data